[go: up one dir, main page]

AU2002215923A1 - Use of medicaments - Google Patents

Use of medicaments

Info

Publication number
AU2002215923A1
AU2002215923A1 AU2002215923A AU1592302A AU2002215923A1 AU 2002215923 A1 AU2002215923 A1 AU 2002215923A1 AU 2002215923 A AU2002215923 A AU 2002215923A AU 1592302 A AU1592302 A AU 1592302A AU 2002215923 A1 AU2002215923 A1 AU 2002215923A1
Authority
AU
Australia
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215923A
Inventor
Steven Etheridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002215923A1 publication Critical patent/AU2002215923A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002215923A 2000-10-06 2001-10-05 Use of medicaments Abandoned AU2002215923A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0024517.5A GB0024517D0 (en) 2000-10-06 2000-10-06 Use of medicaments
GB0024517 2000-10-06
PCT/EP2001/011498 WO2002028394A1 (en) 2000-10-06 2001-10-05 Use of medicaments

Publications (1)

Publication Number Publication Date
AU2002215923A1 true AU2002215923A1 (en) 2002-04-15

Family

ID=9900800

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215923A Abandoned AU2002215923A1 (en) 2000-10-06 2001-10-05 Use of medicaments

Country Status (6)

Country Link
US (1) US20040023962A1 (en)
EP (1) EP1322312A1 (en)
JP (1) JP2004510737A (en)
AU (1) AU2002215923A1 (en)
GB (1) GB0024517D0 (en)
WO (1) WO2002028394A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323268T3 (en) * 2002-07-29 2009-07-10 Glaxo Group Ltd PROLONGED RELEASE FORMULATIONS CONTAINING LAMOTRIGINE.
KR20090085071A (en) * 2006-10-27 2009-08-06 얀센 파마슈티카 엔.브이. Methods of treating cochlear and vestibular disorders
RU2414901C2 (en) * 2009-05-18 2011-03-27 Государственное образовательное учреждение высшего профессионального образования Читинская государственная медицинская академия Росздрава Medication, providing neuro-protective action in acute period of craniocerebral injury

Also Published As

Publication number Publication date
WO2002028394A1 (en) 2002-04-11
JP2004510737A (en) 2004-04-08
US20040023962A1 (en) 2004-02-05
GB0024517D0 (en) 2000-11-22
EP1322312A1 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2002222853A1 (en) Therapeutic compounds
AU2002258063A1 (en) Medicament applicator
AU2002365120A1 (en) Medicaments
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2002223028A1 (en) Inhaler
AU2002253039A1 (en) Tramadol-based medicament
AU2002258221A1 (en) Medicinal composition
AU2001233208A1 (en) Human sulfatases
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002231206A1 (en) Treatment of depression
AU2001243515A1 (en) Combination drug therapy
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001232244A1 (en) Drug comprising combination
AU2002227925A1 (en) Human beta-defensin-3
AU2001273903A1 (en) Therapeutic agents
AU2001261552A1 (en) Disposable respirator
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU4432001A (en) Trityl-type compounds and their use
AU2001272718A1 (en) Medicaments
AU2002215923A1 (en) Use of medicaments
AU2001275696A1 (en) Therapeutic agent
AU2002354460A1 (en) Medicinal composition